Follow The Filings

INGN Inogen

Inogen earnings company data as of 8:02 PM ET 10/22

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by INGN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All INGN insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $142K sold by 1 insider under 10b5-1 plans
  1. Boyer Jennifer M Yi EVP Entrprs Enblmnt, Ch HR Off
    Planned sale
    $72K 10,938 shares at $6.60 69% of stake
    Traded Jul 1 Filed Jul 6
    ↗
  2. Boyer Jennifer M Yi EVP Entrprs Enblmnt, Ch HR Off
    Planned sale
    $70K 10,770 shares at $6.53 40% of stake
    Traded May 29 Filed Jun 2
    ↗

Also filed in the last 12 months, not counted as buying or selling: 19 share withholdings for taxes, 18 stock grants, and 15 option exercises.

SEC filings

Recent issuer filings from EDGAR, 16 shown.

Filed Form Detail Links
8-K 1.01,7.01,8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
DEF 14A Filing Doc
8-K 1.01,5.02,7.01,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-K Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.